RTP Mobile Logo

Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)

Bortezomib-Based Maintenance Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma (MM)

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (MM) or MM in the Post-TransplantSetting

Carfilzomib/Lenalidomide/Dexamethasone (CRd) as Initial Therapy for Patients with Newly Diagnosed Multiple Myeloma (MM)

Module III: Dr Robert Dreicer

Cancer Educators Slide Library: Management of Dermatologic Toxicities

Module II: Dr Stephen Freedland

PCUTT — Module I: Dr Judd W Moul

Subscription | Cancel Subscription Request

Please fill out the form below if you no longer wish to receive our printed material. Allow four to six weeks processing time to have your subscription canceled.

To subscribe to our programs, click here.

Monday Night with Research To Practice: Seminar VIII — Advanced Prostate Cancer

Monday Night with Research To Practice: Seminar VII — Diffuse Large B-Cell Lymphoma (DLBCL)/T-Cell Lymphomas (TCL)/Mantle-Cell Lymphoma (MCL)

Cancer Educators Slide Library: Case Scenarios and Management of Skin Toxicity

Monday Night with Research To Practice: Seminar VI — HER2-Positive Gastric Cancer

Monday Night with Research To Practice: Seminar V — Central Nervous System (CNS) Cancers

Meet The Professors: Oncologist and Nurse Investigators Consult on Challenging Cases of Actual Patients

Meet The Professors: Oncologist and Nurse Investigators Consult on Challenging Cases of Actual Patients